These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12109355)

  • 21. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate.
    Liao S; Umekita Y; Guo J; Kokontis JM; Hiipakka RA
    Cancer Lett; 1995 Sep; 96(2):239-43. PubMed ID: 7585463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of lung cancer by tea.
    Clark J; You M
    Mol Nutr Food Res; 2006 Feb; 50(2):144-51. PubMed ID: 16425282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer.
    Giudice A; Montella M; Boccellino M; Crispo A; D'Arena G; Bimonte S; Facchini G; Ciliberto G; Botti G; Quagliuolo L; Caraglia M; Capunzo M
    Curr Mol Med; 2017; 17(6):405-420. PubMed ID: 29256350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer chemoprevention: current status and future prospects.
    Gupta S
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic administration of green tea extract to TRAMP mice induces the collapse of Golgi apparatus in prostate secretory cells and results in alterations of protein post-translational processing.
    Davalli P; Rizzi F; Caldara GF; Davoli S; Corti A; Silva A; Astancolle S; Vitale M; Bettuzzi S; Arcari M; Azzali G
    Int J Oncol; 2011 Dec; 39(6):1521-7. PubMed ID: 21935569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of green tea catechins in patients with high-grade prostatic intraepithelial neoplasia: Results of a short-term double-blind placebo controlled phase II clinical trial.
    Micali S; Territo A; Pirola GM; Ferrari N; Sighinolfi MC; Martorana E; Navarra M; Bianchi G
    Arch Ital Urol Androl; 2017 Oct; 89(3):197-202. PubMed ID: 28969404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Green Tea Catechin ECG and Its Synthesized Fluorinated Analogue on Prostate Cancer Cells and Stimulated Immunocompetent Cells.
    Stadlbauer S; Steinborn C; Klemd A; Hattori F; Ohmori K; Suzuki K; Huber R; Wolf P; Gründemann C
    Planta Med; 2018 Jul; 84(11):813-819. PubMed ID: 29466808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells.
    Gupta S; Ahmad N; Nieminen AL; Mukhtar H
    Toxicol Appl Pharmacol; 2000 Apr; 164(1):82-90. PubMed ID: 10739747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Green tea: prevention and treatment of cancer by nutraceuticals.
    Béliveau R; Gingras D
    Lancet; 2004 Sep 18-24; 364(9439):1021-2. PubMed ID: 15380952
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison.
    Cui K; Li X; Du Y; Tang X; Arai S; Geng Y; Xi Y; Xu H; Zhou Y; Ma W; Zhang T
    Oncotarget; 2017 May; 8(22):36674-36684. PubMed ID: 28415774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two stages of cancer prevention with green tea.
    Fujiki H
    J Cancer Res Clin Oncol; 1999 Nov; 125(11):589-97. PubMed ID: 10541965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins.
    Kumar NB; Pow-Sang J; Spiess PE; Park J; Salup R; Williams CR; Parnes H; Schell MJ
    Oncotarget; 2016 Oct; 7(43):70794-70802. PubMed ID: 28053292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.
    Stuart EC; Scandlyn MJ; Rosengren RJ
    Life Sci; 2006 Nov; 79(25):2329-36. PubMed ID: 16945390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.
    Rocha S; Generalov R; Pereira Mdo C; Peres I; Juzenas P; Coelho MA
    Nanomedicine (Lond); 2011 Jan; 6(1):79-87. PubMed ID: 21182420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of animal models in defining efficacy of chemoprevention agents against prostate cancer.
    Bosland MC
    Eur Urol; 1999; 35(5-6):459-63. PubMed ID: 10325505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new function of green tea: prevention of lifestyle-related diseases.
    Sueoka N; Suganuma M; Sueoka E; Okabe S; Matsuyama S; Imai K; Nakachi K; Fujiki H
    Ann N Y Acad Sci; 2001 Apr; 928():274-80. PubMed ID: 11795518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. More evidence for green tea's unusual chemoprevention activity.
    Integr Cancer Ther; 2002 Dec; 1(4):422. PubMed ID: 14696635
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemoprevention of nonmelanoma skin cancer: experience with a polyphenol from green tea.
    Linden KG; Carpenter PM; McLaren CE; Barr RJ; Hite P; Sun JD; Li KT; Viner JL; Meyskens FL
    Recent Results Cancer Res; 2003; 163():165-71; discussion 264-6. PubMed ID: 12903852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells.
    Tokar EJ; Webber MM
    Clin Exp Metastasis; 2005; 22(3):265-73. PubMed ID: 16158254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catechins and Its Role in Chronic Diseases.
    Shirakami Y; Sakai H; Kochi T; Seishima M; Shimizu M
    Adv Exp Med Biol; 2016; 929():67-90. PubMed ID: 27771921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.